Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Karpus Management, Inc. TRAD APEX Tech Acquisition Inc. 13G 8.22% 3mo
Squadron Capital Management LLC RLMD Relmada Therapeutics, Inc. 13G/A 7% 3mo
DISCIPLINED GROWTH INVESTORS INC /MN SPSC Sps Commerce Inc 13G 5.9% 3mo
Fund 1 Investments, LLC FLWS 1 800 Flowers Com Inc 13G/A 9.6% 3mo
Point72 Asset Management, L.P. CTMX CytomX Therapeutics, Inc. 13G/A 3.6% 3mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC VECA Vernal Capital Acquisition Corp. 13G 7.5% 3mo
ZAZOVE ASSOCIATES LLC BHR Braemar Hotels & Resorts Inc. 13G/A 7.6% 3mo
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. RFIL R F Industries Ltd 13G/A 5.4% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ FCN Fti Consulting, Inc 13G 6.6% 3mo
Madison Avenue Partners, LP TBPH Theravance Biopharma, Inc. 13G/A 17.7% 3mo
Karpus Management, Inc. IIF Morgan Stanley India Investment Fund, Inc. 13G 5.09% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ TWST Twist Bioscience Corp 13G 5.8% 3mo
G1 Execution Services, LLC MED Medifast Inc 13G 5.3% 3mo
CARRONADE CAPITAL MANAGEMENT, LP BNO United States Brent Oil Fund, LP 13G 8.6% 3mo
Harraden Circle Investments, LLC BEAG Bold Eagle Acquisition Corp. 13G/A 9.11% 3mo
COHEN & STEERS, INC. NTST NETSTREIT Corp. 13G/A 16.75% 3mo
GOLDMAN SACHS GROUP INC AEXA American Exceptionalism Acquisition Corp. A 13G/A 4.2% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ SWKS Skyworks Solutions, Inc. 13G 7.8% 3mo
GLENVIEW CAPITAL MANAGEMENT, LLC DXC DXC Technology Co 13G/A 0% 3mo
AMERIPRISE FINANCIAL INC TREE LendingTree, Inc. 13G 5% 3mo
EARNEST PARTNERS LLC PZZA Papa Johns International Inc 13G/A 8.8% 3mo
COOPER CREEK PARTNERS MANAGEMENT LLC GSM Ferroglobe PLC 13G/A 7.3% 3mo
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP AZTR Azitra, Inc. 13G 8.4% 3mo
ARMISTICE CAPITAL, LLC PWCM Powercompute, Inc. 13G/A 9.99% 3mo
Nantahala Capital Management, LLC AVTX Avalo Therapeutics, Inc. 13G/A 3.54% 3mo
Pentwater Capital Management LP TXNM Txnm Energy Inc 13G 5.9% 3mo
T. Rowe Price Investment Management, Inc. STVN Stevanato Group S.p.A. 13G/A 0% 3mo
Fourthstone LLC FMBM F&M Bank Corp 13G/A 8.97% 3mo
Brian Chesky ABNB Airbnb, Inc. 13G/A 13.6% 3mo
J. Goldman & Co LP ANDG Andersen Group Inc. 13G/A 5.94% 3mo
Deep Track Capital, LP AVTX Avalo Therapeutics, Inc. 13G/A 6.87% 3mo
EdgePoint Investment Group Inc. MAT Mattel Inc 13G/A 17.57% 3mo
ARMISTICE CAPITAL, LLC GIPR Generation Income Properties, Inc. 13G 9.99% 3mo
GATES FOUNDATION TRUST MXF Mexico Fund Inc 13G/A 4.5% 3mo
Fund 1 Investments, LLC JILL J.Jill, Inc. 13G 8.89% 3mo
RWWM, Inc. CRI Carters Inc 13G/A 3.9% 3mo
FARALLON CAPITAL MANAGEMENT LLC IFRX InflaRx N.V. 13G/A 2.3% 3mo
T. Rowe Price Investment Management, Inc. EQBK Equity Bancshares Inc 13G/A 11.4% 3mo
Paul B Manning LQDA Liquidia Corp 13G/A 6.5% 3mo
COHEN & STEERS, INC. HPP Hudson Pacific Properties, Inc. 13G/A 18.23% 3mo
Fourthstone LLC ISTR Investar Holding Corp 13G/A 2.34% 3mo
Ravi Mhatre NTSK Netskope Inc 13G/A 8.4% 3mo
AMERIPRISE FINANCIAL INC UEIC Universal Electronics Inc 13G/A 8.1% 3mo
American Century Investment Management, Inc. CVEO Civeo Corp 13G/A 5.8% 3mo
Polar Asset Management Partners Inc. QRED QuasarEdge Acquisition Corp 13G 6.2% 3mo
Ravi Mhatre BLND Blend Labs, Inc. 13G/A 0% 3mo
Orbis Investment Management Limited PTLO Portillo's Inc. 13G/A 5.7% 3mo
METEORA CAPITAL, LLC YCY AA Mission Acquisition Corp. II 13G/A 1.15% 3mo
Cormorant Asset Management, LP IRLA IRulya Therapeutics Inc. 13G 9.99% 3mo
BIOTECHNOLOGY VALUE FUND L P AVTX Avalo Therapeutics, Inc. 13G/A 5.3% 3mo